阅读说明：本技术 取代的氮杂环丁烷二氢噻吩并吡啶类化合物及其作为磷酸二酯酶抑制剂的用途 (Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors ) 是由 M·安德鲁斯 D·R·格雷夫 B·诺雷马克 于 2018-12-14 设计创作，主要内容包括：本发明涉及具有磷酸二酯酶抑制活性的新型取代的氮杂环丁烷二氢噻吩并吡啶类化合物及其在治疗中的用途、包含所述化合物的药物组合物以及用化合物(I)治疗疾病的方法。<Image he="426" wi="700" file="DDA0002630966310000011.GIF" imgContent="drawing" imgFormat="GIF" orientation="portrait" inline="no"></Image>(The present invention relates to novel substituted azetidine dihydrothienopyridines having phosphodiesterase inhibitory activity and their use in therapy, pharmaceutical compositions comprising said compounds and methods of treating diseases with compound (I).)